NO20022847D0 - Nye substituerte tricykliske forbindelser - Google Patents

Nye substituerte tricykliske forbindelser

Info

Publication number
NO20022847D0
NO20022847D0 NO20022847A NO20022847A NO20022847D0 NO 20022847 D0 NO20022847 D0 NO 20022847D0 NO 20022847 A NO20022847 A NO 20022847A NO 20022847 A NO20022847 A NO 20022847A NO 20022847 D0 NO20022847 D0 NO 20022847D0
Authority
NO
Norway
Prior art keywords
tricyclic compounds
new substituted
substituted tricyclic
new
compounds
Prior art date
Application number
NO20022847A
Other languages
English (en)
Other versions
NO20022847L (no
Inventor
Shiro Miyoshi
Kohei Ogawa
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of NO20022847D0 publication Critical patent/NO20022847D0/no
Publication of NO20022847L publication Critical patent/NO20022847L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022847A 1999-12-16 2002-06-14 Nye substituerte tricykliske forbindelser NO20022847L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35691499 1999-12-16
PCT/JP2000/008816 WO2001044187A1 (fr) 1999-12-16 2000-12-13 Nouveaux composes tricycliques substitues

Publications (2)

Publication Number Publication Date
NO20022847D0 true NO20022847D0 (no) 2002-06-14
NO20022847L NO20022847L (no) 2002-08-14

Family

ID=18451407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022847A NO20022847L (no) 1999-12-16 2002-06-14 Nye substituerte tricykliske forbindelser

Country Status (8)

Country Link
US (1) US20030040538A1 (no)
EP (1) EP1238973A4 (no)
KR (1) KR20020069215A (no)
CN (1) CN1423637A (no)
AU (1) AU1888501A (no)
CA (1) CA2394778A1 (no)
NO (1) NO20022847L (no)
WO (1) WO2001044187A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407538C (en) 2000-04-28 2007-01-09 Asahi Kasei Kabushiki Kaisha Novel bicyclic compounds
JPWO2002074306A1 (ja) * 2001-03-19 2004-07-08 旭化成ファーマ株式会社 脂肪肝治療薬
KR100622461B1 (ko) * 2001-10-25 2006-09-19 아사히 가세이 파마 가부시키가이샤 2환식 화합물
FR2840304B1 (fr) * 2002-05-29 2007-05-18 Sanofi Synthelabo Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
JP2007533753A (ja) * 2004-04-23 2007-11-22 タケダ サン ディエゴ インコーポレイテッド インドール誘導体及びキナーゼ阻害剤としてのその使用
KR20080067346A (ko) 2005-11-15 2008-07-18 신젠타 파티서페이션즈 아게 비페닐의 제조방법
WO2008051523A2 (en) * 2006-10-23 2008-05-02 Georgetown University Carbazole derivatives useful as medicaments in cancer therapy
WO2010019271A1 (en) 2008-08-15 2010-02-18 Georgetown University Fluorescent regulators of rassf1a expression and human cancer cell proliferation
JPWO2010041569A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール化合物
CN102171191A (zh) * 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
US20100173829A1 (en) * 2008-11-07 2010-07-08 Aston University Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof
CA2873214C (en) * 2012-05-11 2021-02-16 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
WO2017023916A1 (en) * 2015-08-05 2017-02-09 Georgetown University Small molecule androgen receptor inhibitors and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816457A (en) * 1980-12-23 1989-03-28 Baldwin John J Aralkylaminoethanol heterocyclic compounds
DE3612831A1 (de) * 1986-04-16 1987-10-22 Basf Ag 1,4-cyclohexandiamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
ATE154935T1 (de) * 1993-06-14 1997-07-15 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
AU715233B2 (en) * 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
ES2149742T1 (es) * 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
KR20010080761A (ko) * 1998-12-15 2001-08-22 야마모토 카즈모토 신규한 복소환 화합물 및 이를 함유하는 의약 조성물

Also Published As

Publication number Publication date
CA2394778A1 (en) 2002-06-14
NO20022847L (no) 2002-08-14
US20030040538A1 (en) 2003-02-27
CN1423637A (zh) 2003-06-11
WO2001044187A1 (fr) 2001-06-21
EP1238973A4 (en) 2003-01-22
KR20020069215A (ko) 2002-08-29
EP1238973A1 (en) 2002-09-11
AU1888501A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
NO20020814D0 (no) Nye spiroforbindelser
NO20033715L (no) Nye sammensetninger
IS6024A (is) Ný efnasambönd
EE200200033A (et) Uued ühendid
EE200200224A (et) Uudsed ühendid
NO991821D0 (no) Substituerte tricykliske forbindelser
NO20020810D0 (no) Nye fenylpiperaziner
IS6139A (is) Ný efnasambönd
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20015074L (no) Nye sammensetninger
NO20022847D0 (no) Nye substituerte tricykliske forbindelser
PT1144411E (pt) Compostos espiro anti-histaminicos
NO991823D0 (no) Substituerte tricykliske forbindelser
IS6141A (is) Ný efnasambönd
ATE259816T1 (de) Tricyclische benzoylcyclohexandion-derivate
SE9900086D0 (sv) New compounds
SE9904228D0 (sv) New compounds
SE9904418D0 (sv) New compounds
SE9904420D0 (sv) New compounds
SE9902762D0 (sv) New compounds
SE9904422D0 (sv) New compounds
SE9900071D0 (sv) New compounds
SE9901118D0 (sv) Novel compounds
SE9901270D0 (sv) Novel compounds
SE9901117D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application